Contract 75A50124C00044

Wake Forest University Health Sciences · Department Of Health And Human Services · September 21, 2024

Cost No FeeFull & Open CompetitionNAICS 541715

Wake Forest University Health Sciences was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 21, 2024 for $22.09 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Winston Salem, NC. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on July 7, 2025. If all options are exercised, the contract could reach $48.63 million.

Obligated to date
$22.09M
$22,092,307
Current value
$22.09M
Potential value
$48.63M
if all options exercised
Modifications
1
Latest July 7, 2025

Contract details

PIID
75A50124C00044
Award type
Definitive Contract
Pricing
Cost No Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
Product / service
Specialized Medical Support
Place of performance
Winston Salem, NC
First action
September 21, 2024
Latest action
July 7, 2025

Description

TRANSFER SCIENTIFIC EQUIPMENT FROM CONTRACT 75A50119C00058 TO CONTRACT 75A50124C00044 AND EXERCISE OPTION PERIOD 002 CLIN 003.

Modification timeline

  • July 7, 2025
    Mod P00002 · Supplemental Agreement For Work Within Scope
    $22.09M
  • September 21, 2024
    Base award
    BASE PERIOD AWARD HUMAN ORGAN TISSUE EQUIVALENT MODELS OF FIBROSING CHEMICAL EXPOSURE TO BRIDGE PRECLINICAL AND CLINICAL TRANSLATION OF MEDICAL COUNTERMEASURES
    $17.89M

Similar contracts

RecipientAgencyDateObligated
The Emmes Company, LlcDepartment Of Health And Human ServicesApril 1, 2026$771.5K
Leidos Biomedical Research IncDepartment Of Health And Human ServicesApril 1, 2026$327.13M
Leidos Biomedical Research IncDepartment Of Health And Human ServicesApril 1, 2026$8.00M
Lovelace Biomedical Research InstituteDepartment Of Health And Human ServicesApril 1, 2026$680.2K
Leidos Biomedical Research IncDepartment Of Health And Human ServicesApril 1, 2026$9.22M
The Brain Donor Project, IncDepartment Of Health And Human ServicesApril 1, 2026$1.27M

Top contractors in NAICS 541715

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Fluor Marine Propulsion, Llc2$2.75B
2California Institute Of Technology240$979.40M
3The Johns Hopkins University Applied Physics Laboratory Llc204$482.74M
4Lockheed Martin Corporation4$461.91M
5Lockheed Martin Corp9$317.27M
6The Aerospace Corporation85$308.18M
7Fermi Forward Discovery Group, Llc1$289.92M
8Lockheed Martin Corp7$285.45M
9Amentum Technology, Inc.4$253.24M
10The Mitre Corporation50$222.51M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75A50124C00044?

Contract 75A50124C00044 is a federal contract awarded to Wake Forest University Health Sciences by Department Of Health And Human Services on September 21, 2024 for $22.09 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 1 time since the base award.

Who won contract 75A50124C00044?

Wake Forest University Health Sciences won contract 75A50124C00044 from Department Of Health And Human Services.

How much is contract 75A50124C00044 worth?

Contract 75A50124C00044 has obligated $22.09 million to date, with a total potential value of $48.63 million if all options are exercised.